Biotech · Private company
Kamau Therapeutics
Track this companyFree. Adds Kamau Therapeutics to your Dealase workspace and tells you when its record changes.
Clinical trials11 recruiting or active
Pipeline programs1From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline1
- nula-cel Drug ProductPhase 2 · Sickle Cell DiseaseClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials1
- Gene Correction in Autologous CD34+ Hematopoietic Stem Cells (HbS to HbA) to Treat Severe Sickle Cell DiseasePHASE1_PHASE2 · RECRUITING · started Nov 15, 2021ClinicalTrials.gov NCT04819841 · fetched Nov 12, 2026